# Severe PID With Lymphoproliferation and Neutropenia

> **NCT03427593** · NA · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 27 (actual)

## Conditions studied

- Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)

## Interventions

- **GENETIC:** FACS analyses
- **GENETIC:** Target Sequencing by NGS ( Next-generation sequencing)
- **GENETIC:** Whole Exome Sequencing

## Key facts

- **NCT ID:** NCT03427593
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-13
- **Primary completion:** 2018-03-13
- **Final completion:** 2019-12-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427593, "Severe PID With Lymphoproliferation and Neutropenia". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT03427593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*